Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to test the safety and observe the pharmacokinetics (distribution and elimination of the drug) of the compound dexanabinol (ETS2101) in healthy male subjects following a single oral dose.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: e-Therapeutics PLC
• Treatments: Dronabinol; HU 211

Criteria

Inclusion Criteria:

• Healthy males aged 18 to 45 years

• Body mass index 18.0 to 32.0 kg/m2, or if outside the range, considered not clinically significant by the investigator

Exclusion Criteria:

• Participation in a clinical research study within the previous 3 months

• Current smokers and those who have smoked within the last 12 months

• History of any drug or alcohol abuse in the past 2 years